Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effects of propafenone on sinus node function in the rabbit heart.

C R Kerr1

  • 1Department of Medicine, University of British Columbia, Vancouver, Canada.

Canadian Journal of Physiology and Pharmacology
|July 1, 1990
PubMed
Summary

Propafenone, an antiarrhythmic drug, significantly prolongs the sinus node effective refractory period (SNERP) and atriosinus conduction time (ASCT) in rabbit sinus node preparations. These findings highlight propafenone

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

We must act now and invest in Canada's heart healthy future.

The Canadian journal of cardiology·2009
Same author

Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: waiting times and access to care issues.

The Canadian journal of cardiology·2005
Same author

Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators.

Journal of the American College of Cardiology·2001
Same author

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome.

Circulation·2001
Same author

Circadian variation of paroxysmal atrial fibrillation. PA3 Investigators. Atrial Pacing Peri-ablation for Prevention of Atrial Fibrillation Trial.

The American journal of cardiology·2001
Same author

Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.

The New England journal of medicine·2001

Area of Science:

  • Pharmacology
  • Cardiac Electrophysiology

Background:

  • Propafenone is a Class 1C antiarrhythmic agent used to treat ventricular and supraventricular arrhythmias.
  • Understanding its effects on sinus node function is crucial for managing cardiac rhythm disorders.

Purpose of the Study:

  • To investigate the in vitro effects of propafenone on sinus node function in a rabbit model.
  • To assess propafenone's impact on spontaneous sinus cycle length (SCL), atriosinus conduction time (ASCT), and sinus node effective refractory period (SNERP).

Main Methods:

  • Isolated rabbit sinus node and atrial preparation.
  • Measurement of SCL, ASCT, and SNERP under control conditions.
  • Superfusion with propafenone (2.3 microM) and repeated measurements.

Related Experiment Videos

Main Results:

  • Propafenone significantly prolonged SNERP from 175 ± 25 ms to 220 ± 45 ms (p < 0.001).
  • ASCT was also significantly prolonged by propafenone, from 50 ± 20 ms to 65 ± 20 ms (p < 0.01).
  • Spontaneous sinus cycle length (SCL) remained unchanged. A dose-dependent effect on SNERP was observed.

Conclusions:

  • Propafenone significantly impacts sinus node function by prolonging SNERP and ASCT.
  • These electrophysiological effects may contribute to the antiarrhythmic properties of propafenone.
  • The study provides in vitro evidence of propafenone's direct effects on sinus node conduction and refractoriness.